Technology
100 Most Popular
Health

Moderna

$65.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.99 (-2.96%) Today
+$0.18 (+0.28%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Moderna and other stocks, options, ETFs, and crypto commission-free!

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Read More The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. The listed name for MRNA is Moderna, Inc. Common Stock.

CEO
Stéphane Bancel
Employees
830
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
25.72B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.95M
High Today
$66.77
Low Today
$63.64
Open Price
$65.50
Volume
5.56M
52 Week High
$95.21
52 Week Low
$13.53

Collections

Technology
100 Most Popular
Health
Biotechnology
Therapy
Cancer Prevention
2018 IPO
US

Digestible Financial News

Jack Kramer & Nick Martell

Managing Editors of News & Snacks at Robinhood Financial LLC

MRNA News

Benzinga9h

Moderna Analyst On 4 Coronavirus Vaccine Program Risks

Moderna Inc (NASDAQ: MRNA) is one of the frontrunners in a crowded race to develop a vaccine against the novel coronavirus. Despite Moderna's strong positioning
Benzinga22h

FDA Vaccine Committee Head Steps Aside Over Conflict Of Interest With Moderna Role

The head of the United States Food and Drug Administration’s vaccine advisory committee has recused herself from the panel due to her involvement in supervising
ReutersSep 18

Moderna sees 20 million doses of COVID-19 vaccine candidate by year end

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massa

MRNA Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 4, Pre-Market

You May Also Like

VXZ
PDCO
PDM
NMK-C
IGV
SFE
LNT
VDE
ACI
ETHO

More MRNA News

ReutersSep 18

Moderna expects to make 20 mln doses of coronavirus vaccine by 2020 end

Sept 18 (Reuters) - Moderna Inc said on Friday it expects to produce 20 million doses of its experimental coronavirus vaccine by the end of the year. The compa
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy MRNA
Market Price
$65.35
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Moderna stock and options commission-free.
LearnBlogCareersHelpLog InSign Up